By Kamal Choudhury March 26 (Reuters) - Wave Life Sciences shares plunged 58% on Thursday after a higher dose of its experimental obesity drug failed to show a clear improvement at reducing a ...

On March 26, 2026, traders mulled Wave's weak high-dose obesity results against the company's large market opportunity.

Wave Life Sciences (WVE) stock plunges as the company interim data from an early-stage trial for WVE-007, its RNA-based ...

Wave Life Sciences (NASDAQ:WVE) shares are trading near historic lows after two Wall Street firms cut their price targets ...

Hello, and welcome to Wave Life Sciences Positive Interim Phase I Clinical Data from INLIGHT Trial of WVE-007 for Obesity Call. [Operator Instructions] Also, as a reminder, this conference is being ...

SELLAS Life Sciences Group Inc. (NASDAQ:SLS) is one of the popular penny stocks on Robinhood to buy. On March 17, SELLAS Life ...

Read about the new Biocom Octane partnership. Discover how this collaboration expands capital and accelerator access for ...

Anavex Life Sciences Corp. AVXL shares are tumbling on Wednesday after the company announced it has withdrawn its application ...

Wave Life Sciences Ltd. WVE shares are tumbling on Thursday following the announcement of interim Phase 1 data from its ...

W hile challenges persist in the short term, there are signs pointing toward long-term growth for life sciences, according to JLL’s 2024 Life Sciences Real Estate Perspective and Cluster Analysis. The ...

Dr. Mark Turco "will step down" from his role with the Hub Wednesday, March 11, to lead a medical device company.

When Hurricane Helene tore through Western North Carolina in September 2024, it didn't just uproot trees and wash out roads.